Czarnota-Lydka K, Sudol-Talaj S, Kucwaj-Brysz K, Kurczab R, Satala G, de Candia M, Samarelli F, Altomare CD, Carocci A, Barbarossa A, eslawska E, Gluch-Lutwin M, Mordyl B, Kubacka M, Wilczynska-Zawal N, Jastrzebska-Wiesek M, Partyka A, Khan N, Wiecek M, Nitek W, Honkisz-Orzechowska E, Latacz G, Wesolowska A, Carrieri A, Handzlik J (2023)
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT(6)R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
Eur Journal of Medicinal Chemistry 259: 115695

Wichur T, Godyn J, Goral I, Latacz G, Bucki A, Siwek A, Gluch-Lutwin M, Mordyl B, Sniecikowska J, Walczak M, Knez D, Jukic M, Salat K, Gobec S, Kolaczkowski M, Malawska B, Brazzolotto X, Wieckowska A (2021)
Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with beta-amyloid anti-aggregation properties
Eur Journal of Medicinal Chemistry 225: 113792

Malek R, Arribas RL, Palomino-Antolin A, Totoson P, Demougeot C, Kobrlova T, Soukup O, Iriepa I, Moraleda I, Diez-Iriepa D, Godyn J, Panek D, Malawska B, Gluch-Lutwin M, Mordyl B, Siwek A, Chabchoub F, Marco-Contelles J, Kiec-Kononowicz K, Egea J, de los Rios C, Ismaili L (2019)
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
Journal of Medicinal Chemistry 62: 11416